publication date: Dec. 26, 2010

In this issue: 

Dear ASCO Member Letter From Klausner Attempts To Rescue Flagging BMT Trial.

McKay Retires As Fox Chase Executive, Is Succeeded By Donald Leedy As VP.

ASCO Foundation Raised $200,000 In Its First Year.

ASCO Selects Three Cities For Quality Of Care Study.

Early Detection Network Completes Initial Funding From NCI.

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

Pharmacia Corp. Forms $1 Million Fund To Support Anthracycline Research.

One Health Plan, Genzyme Agree On Genetic Testing.

ECOG To Cease Participation In Melanoma Vaccine Study.

Vysis, Genentech In Agreement On HER-2 Breast Cancer Test.

Myriad Wins Patent For p10 Tumor Suppressor Gene.

Download (PDF 377KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.